DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epzicom (Abacavir Sulfate / Lamivudine) - Current Clinical Trials

 
 



Epzicom Related Clinical Trials

Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment [Recruiting]

Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment [Active, not recruiting]

Pharmacokinetic Study Of EPZICOM Tablet [Completed]

Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects [Recruiting]

Artery Elasticity After Switch From Epzicom to Truvada [Recruiting]

ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial [Recruiting]

A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE) [Recruiting]

A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT [Recruiting]

ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial [Recruiting]

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV [Active, not recruiting]

A Randomised, Open-Label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-Emtricitabine or Abacavir-Lamivudine: The STEAL Study [Recruiting]

Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir) [Active, not recruiting]

A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults [Completed]

Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment [Active, not recruiting]

Safety of and Immune Response to Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults With Acute HIV Infection [Active, not recruiting]

Safety and Efficacy Study of Switching From Epzicom to Truvada [Recruiting]

A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination [Active, not recruiting]

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection [Completed]

Changing to Nonprotease Inhibitor Treatment to Improve Side Effects [Completed]

Blood Levels of Abacavir in HIV Infected Adolescents [Completed]

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV [Active, not recruiting]

Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy [Recruiting]

Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects [Recruiting]

KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects [Completed]

Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients [Recruiting]

Study of Options for Second-Line Effective Combination Therapy (SELECT) [Recruiting]

Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients [Completed]

A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women [Active, not recruiting]

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children [Completed]

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection [Active, not recruiting]

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320 [Completed]

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients [Completed]

A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection [Completed]

A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART) [Completed]

A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients [Completed]

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV [Completed]

Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination [Completed]

A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89 [Completed]

A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex [Completed]

A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection [Completed]

A Study of 1592U89 in HIV-Infected Children [Completed]

A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients [Completed]

A Study of 1592U89 in HIV-Infected Adults [Completed]

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects. [Completed]

An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen [Completed]

The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors [Completed]

A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs [Completed]

A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment [Completed]

A Study of a Combination of Four Drugs in Patients With Recent HIV Infection [Completed]

A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults [Completed]

A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients [Completed]

A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [Suspended]

A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs [Completed]

A Study of 1592U89 in HIV-Infected Patients [Completed]

A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients [Completed]

The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs [Completed]

The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs [Completed]

The Effect of Teaching HIV-Infected Patients About HIV and Treatment [Completed]

Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment [Completed]

A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir [Completed]

A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [Completed]

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks [Completed]

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection [Active, not recruiting]

Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily [Completed]

Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults [Recruiting]

Abacavir Pharmacokinetic Study [Recruiting]

MARCH Vascular Endothelium Substudy [Recruiting]

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects [Completed]

A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients [Completed]

Clinical Trial of CNS-targeted HAART (CIT2) [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014